{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-127673","form_type":"8-K","ticker":"HURA","cik":"0001498382","company_name":"TuHURA Biosciences, Inc./NV","filed_at":"2024-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.597987+00:00","generated_at":"2026-05-29T23:43:36.509290+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TuHURA raises CEO & CFO base salaries; grants options for 1.56M shares at $4.94","bullets":["CEO Bianco base salary increased to $499,000; CFO Dearborn to $375,000, effective Jan 1, 2025.","Bianco granted options for 1,065,990 shares; Dearborn for 489,848 shares, exercise price $4.94.","Options vest in 1/3 annual installments over 3 years, 10-year term, under 2024 Equity Incentive Plan.","Compensation Committee set salaries at ~80% of peer group 50th percentile.","Approved form of stock option agreement, filed as Exhibit 10.1."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-127673","json":"https://secwatch.observer/filing/0000950170-24-127673.json","markdown":"https://secwatch.observer/filing/0000950170-24-127673.md","text":"https://secwatch.observer/filing/0000950170-24-127673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1498382/000095017024127673/0000950170-24-127673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1498382/000095017024127673/hura-20241115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:43:36.509290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}